AOPs enhance the migration of polystyrene nanoparticles in saturated quartz sand.

Environ Sci Process Impacts

Shandong Key Laboratory of Water Pollution Control and Resource Reuse, School of Environmental Science and Engineering, Shandong University, Qingdao, Shandong Province 266237, P. R. China.

Published: October 2021

Wastewater treatment plants are suspected to be significant point sources of microplastic and nanoplastic particles (NPs) in the environment. As one of the main wastewater treatment processes, advanced oxidation processes (AOPs) may change the physicochemical properties of NPs and further affect their migration. However, limited information is known about the environmental fate of NPs after AOP treatment. In this study, polystyrene nanoparticles were treated using two representative AOPs, Fenton and persulfate treatments, and the migration of the NPs in quartz sand was investigated column transport experiments. FTIR and XPS analysis indicated that a large number of oxygen-containing groups were generated on the NP surface after AOP treatment leading to lower hydrophobicity and a higher negative charge. Besides, the C/O ratio after Fenton and persulfate treatments was increased from 10.98 to 7.25 and 8.68. Moreover, the NPs after AOP treatment exhibited higher mobility in quartz sand in both ultrapure water and 10 mM NaCl solution. It was more obvious in 10 mM NaCl solution with breakthrough percentages of 79.73% for P-PS, 90.97% for F-PS and 95.67% for N-PS, respectively. These results could be explained by the roles of generated oxygen-containing functional groups; first, the higher negative charge enhanced the electrostatic repulsion between treated NPs and sand; second, lower hydrophobicity improved the binding with water molecules in background solution. This work is helpful in understanding the changes of nanoplastics in AOP treatment and their migration in the natural environment, which has far-reaching influence on the environmental fate and behavior of nanoplastics.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d1em00240fDOI Listing

Publication Analysis

Top Keywords

aop treatment
16
quartz sand
12
polystyrene nanoparticles
8
wastewater treatment
8
environmental fate
8
nps aop
8
fenton persulfate
8
persulfate treatments
8
lower hydrophobicity
8
higher negative
8

Similar Publications

Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis.

Thromb Haemost

January 2025

Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Background:  V617F-mutated myeloproliferative neoplasms (MPN) exhibit abnormal proliferation of bone marrow progenitors and increased risk of thrombosis, specifically in splanchnic veins (SVT). The contribution of the endothelium to the development of the prothrombotic phenotype was explored.

Material And Methods:  Plasma and serum samples from V617F MPN patients with (n=26) or without (n=7) thrombotic debut and different treatments, were obtained (n=33).

View Article and Find Full Text PDF

Aim: We evaluated whether sample entropy of heart rate time series could serve as a biomarker for guiding caffeine cessation in preterm infants treated for apnoea of prematurity (AOP). We also assessed associations of sample entropy with weeks of gestation, clinical morbidity, AOP frequency and caffeine reinitiation.

Methods: We conducted a prospective single-centre study at the University Children's Hospital Basel, Switzerland, from July 2019 to June 2020.

View Article and Find Full Text PDF

Introduction: Prasinezumab was shown to potentially delay motor progression in individuals with early-stage Parkinson's disease (PD) who were either treatment-naïve or on monoamine oxidase type B inhibitor (MAO-Bi) therapy in the PASADENA study. We report the rationale, design, and baseline patient characteristics of the PADOVA study, designed to evaluate prasinezumab in an early-stage PD population receiving standard-of-care (SOC) symptomatic medications.

Methods: PADOVA (NCT04777331) is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, in which individuals with early-stage PD on SOC stable symptomatic monotherapy (levodopa or MAO-Bi) receive intravenous prasinezumab 1500 mg every 4 weeks.

View Article and Find Full Text PDF

To meet wastewater treatment quality standards for reuse, integrating advanced oxidation processes (AOPs) with Decentralized Wastewater Treatment Systems (DEWATS) is promising. This study aimed to optimize AOPs (ozonolysis, UV photolysis, TiO photocatalysis) for polishing anaerobic filter (AF) effluent from DEWATS, as an alternative to constructed wetlands. Metrics included pathogen reduction efficiency, post-disinfection regrowth, and effects on physical parameters (pH, EC, turbidity), organic matter (soluble COD, BOD, DOC, humic), and nutrient concentration (ammonium, nitrates, ortho-P).

View Article and Find Full Text PDF

Ventilatory drive is modulated by a variety of neurochemical inputs that converge on spatially oriented clusters of cells within the brainstem. This regulation is required to maintain energy homeostasis and is essential to sustain life across all mammalian organisms. Therefore, the anatomical orientation of these cellular clusters during development must have a defined mechanistic basis with redundant genomic variants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!